Close

Cardiovascular Systems (CSII) Met Primary Endpoint in ORBIT II for Cronary Lesions

March 11, 2013 8:29 AM EDT Send to a Friend
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), presented pivotal 30-day data from its ORBIT II study of severely calcified coronary lesions ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login